Fig. 1 · Structure
Documents & Downloads
Docosyl trans-ferulate
Antiviral Compound
Docosyl trans-ferulate is an antiviral compound that specifically targets HIV-1. It has demonstrated significant anti-HIV-1 activity in anti-syncytial assays utilizing the ΔTat/revMC99 virus and the 1A2 cell line system. This compound can be a valuable tool for researchers investigating HIV-1 pathogenesis and developing antiviral therapies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 101927-24-6 |
| Applications | Antiviral Compound |
| Formula | C32H54O4 |
| Molecular Weight | 502.77 |
| SMILES | CCCCCCCCCCCCCCCCCCCCCCOC(/C=C/C1=CC(OC)=C(C=C1)O)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.